The Anti-Thyroid Drugs market size is expected to reach $2.85 billion in 2030 at a CAGR of 2.9%, driven by rising thyroid disorder diagnosis and improved screening programs.
Read More
The Antispasmodics Drugs market size is expected to reach $23.47 billion in 2030 at a CAGR of 9.5%, driven by growing elderly population and rising gastrointestinal disorder prevalence.
Read More
The Antiseptic Bathing Products market size is expected to reach $28.22 billion in 2030 at a CAGR of 6.0%, driven by rising skin disease prevalence and infection control initiatives.
Read More
The Antisense & RNAi Therapeutics market size is expected to reach $3.53 billion in 2030 at a CAGR of 12.9%, driven by gene-silencing innovation and growing precision medicine adoption.
Read More
The Anti-Rabies Serum market size is expected to reach $1.95 billion in 2030 at a CAGR of 5.3%, driven by rising dog bite incidents and expanded rabies prevention programs.
Read More
The Antipyretic Drugs For Children market size is expected to reach $4.61 billion in 2030 at a CAGR of 6.3%, driven by rising pediatric infections.
Read More
The Antipsychotic Drugs market size is expected to reach $33.26 billion in 2030 at a CAGR of 9.4%, driven by increasing mental health disorders and adoption of long-acting injectable therapies.
Read More
The Anti-Parkinson Drugs market size is expected to reach $14.28 billion in 2030 at a CAGR of 5.6%, driven by rising neurodegenerative disorders and demand for symptom management therapies.
Read More
The Antiparasitic Drugs market size is expected to reach $36.13 billion in 2030 at a CAGR of 7.4%, driven by increasing vector-borne diseases and expanded parasite control programs.
Read More
The Antiobesity market size is expected to reach $6.56 billion in 2030 at a CAGR of 10.0%, driven by rising obesity prevalence and growing adoption of hormone-based weight loss drugs.
Read More